Physician profile
Jeffrey E Zuke
NPI 1386672608
$2,608.07
in general payments reported to CMS, 2019-2025
21 companies · $3.24 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $487 · 2021: $249 · 2022: $476 · 2023: $454 · 2024: $123 · 2025: $3.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554 · Education: $25.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.37 |
| Education | $25.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $944.65 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $407.65 | 2020-2023 | Phasix Mesh |
| Conmed Corporation | $327.80 | 2019 | |
| Allergan, INC. | $146.00 | 2019-2022 | |
| Stryker Corporation | $122.54 | 2024 | Mako |
| Medical Device Business Services, INC. | $121.84 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $100.13 | 2019-2020 | |
| Innocoll Pharmaceuticals Limited | $73.32 | 2021-2022 | |
| Teleflex LLC | $64.15 | 2019-2021 | |
| Shire North American Group INC | $44.54 | 2019 | |
| Heron Therapeutics, INC. | $39.23 | 2023 | Zynrelef |
| Ethicon US, LLC | $35.48 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $34.21 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.57 | 2020 | |
| Acell, INC. | $25.80 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $22.38 | 2019 | |
| Merck Sharp & Dohme LLC | $16.07 | 2019 | |
| Lsi Solutions INC | $13.88 | 2020 | |
| Covidien Lp | $13.41 | 2019 | |
| Tela Bio, INC. | $11.73 | 2021 | |
| Cook Medical LLC | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Zuke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.